When using semaglutide, a common concern is whether caffeine affects the medications effectiveness
Clinicians should consider reducing doses of these medications when initiating semaglutide therapy
Most people begin noticing hunger changes between weeks 4-8, with significant appetite reduction at weeks 8-12
There are several variables to consider in terms of weight loss from injectables containing semaglutide and tirzepatide, such as the brand, dosage, how long the medication is taken, whether the patient has type 2 diabetes, lifestyle changes to diet and exercise in combination with taking the medicine, and other factors
Blood sugar: Blood sugar, particularly hemoglobin A1C, should also be monitored yearly, as it provides a long-term view of average blood sugar levels, especially important for those with diabetes